- Conditions: Autism Spectrum Disorder (ASD); Autism; Autistic Disorder; Asperger's Disorder; Asperger's; Pediatric Autism; Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS); Pervasive Child Development Disorder
Intervention: Drug: Memantine HCl
Sponsors: Forest Laboratories; Forest Laboratories
Not yet recruiting - verified May 2012 - Conditions: Autism Spectrum Disorder (ASD); Autism; Autistic Disorder; Asperger's Disorder; Asperger's; Pediatric Autism; Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS); Pervasive Child Development Disorder
Intervention: Drug: Memantine HCl
Sponsors: Forest Laboratories; Forest Laboratories
Not yet recruiting - verified May 2012 - Conditions: Autism Spectrum Disorder (ASD); Autism; Autistic Disorder; Asperger's Disorder; Asperger's; Pediatric Autism; Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS); Pervasive Child Development Disorder
Interventions: Drug: Memantine HCl; Drug: Memantine HCl; Drug: Placebo capsules
Sponsors: Forest Laboratories; Forest Laboratories
Not yet recruiting - verified May 2012 - Conditions: Autism; Asperger's Syndrome; Generalized Anxiety Disorder; Social Phobia; Separation Anxiety Disorder; Obsessive-compulsive Disorder
Intervention: Behavioral: Computer assisted cognitive behavioral therapy.
Sponsors: University of South Florida; University of South Florida
Recruiting - verified March 2012 - Conditions: Autism; Asperger's Syndrome; Pervasive Developmental Disorder Not Otherwise Specified; Generalized Anxiety Disorder; Social Phobia; Separation Anxiety Disorder; Obsessive-compulsive Disorder
Interventions: Other: Cognitive Behavioral Therapy; Other: Treatment as usual
Sponsors: University of South Florida; University of South Florida
Recruiting - verified March 2012 - Condition: Autism Spectrum Disorders
Intervention: Drug: Arbaclofen
Sponsors: Seaside Therapeutics, Inc.; Seaside Therapeutics, Inc.
Recruiting - verified April 2012 - Conditions: Autism Spectrum Disorder; Asperger Syndrome; Aspergers Syndrome
Interventions: Drug: Milnacipran; Drug: Placebo
Sponsors: Montefiore Medical Center; Montefiore Medical Center; Forest Laboratories
Recruiting - verified April 2012 - Condition: Autism Spectrum Disorders
Interventions: Drug: Intranasal Oxytocin; Drug: Placebo
Sponsors: Montefiore Medical Center; Montefiore Medical Center; National Alliance for Research on Schizophrenia and Depression
Recruiting - verified April 2012 - Condition: Autism Spectrum Disorders
Intervention:
Sponsors: Massachusetts General Hospital; Massachusetts General Hospital; Mclean Hospital
Recruiting - verified December 2011 - Condition: Pervasive Development Disorders
Interventions: Drug: extended-release guanfacine; Other: placebo
Sponsors: Yale University; Yale University; Massachusetts General Hospital; Seattle Children's Hospital; University of California, Los Angeles; National Institute of Mental Health (NIMH)
Recruiting - verified May 2012 - Conditions: Autism; Autism Spectrum Disorder
Interventions: Behavioral: Cognitive Behavioral Therapy (CBT); Behavioral: Play Therapy
Sponsors: Mount Sinai School of Medicine; Mount Sinai School of Medicine; National Institute of Mental Health (NIMH)
Recruiting - verified February 2012 - Conditions: Autism; Asperger's Syndrome; Generalized Anxiety Disorder; Social Phobia; Separation Anxiety Disorder; Obsessive-compulsive Disorder
Interventions: Behavioral: Cognitive-behavioral therapy; Behavioral: Treatment as Usual
Sponsors: University of South Florida; University of South Florida
Recruiting - verified March 2012 - Conditions: Autism Spectrum Disorder; Autism; Asperger's Syndrome; Pervasive Developmental Disorder
Intervention:
Sponsors: Children's Hospital Boston; Children's Hospital Boston
Recruiting - verified February 2012 - Conditions: Autistic Disorder; Asperger's Disorder; Pervasive Developmental Disorder NOS
Interventions: Drug: D-cycloserine; Drug: Placebo
Sponsors: Indiana University; Indiana University; Department of Defense
Recruiting - verified April 2012 - Conditions: Autistic Disorder; Asperger Syndrome; Mental Retardation; Child; Adult
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); National Institute of Mental Health (NIMH)
Recruiting - verified July 2011 - Conditions: Autism; Asperger Disorder; PDD-NOS
Intervention: Other: Cholesterol
Sponsors: National Institutes of Health Clinical Center (CC); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Recruiting - verified April 2012 - Condition: Autism Spectrum Disorders
Intervention:
Sponsors: Children's Hospital Boston; Children's Hospital Boston
Recruiting - verified September 2011 - Condition: Autistic Disorder
Interventions: Behavioral: Cognitive Enhancement Therapy; Behavioral: Enriched Supportive Therapy
Sponsors: University of Pittsburgh; University of Pittsburgh; National Institute of Mental Health (NIMH)
Recruiting - verified January 2012 - Conditions: Autism; Pervasive Developmental Disorder Not Otherwise Specified; Asperger's Disorder; Attention Deficit Hyperactivity Disorder
Interventions: Drug: atomoxetine; Drug: Placebo; Behavioral: Parent Management Training
Sponsors: University of Rochester; University of Rochester; University of Pittsburgh; Ohio State University
Recruiting - verified August 2011
 |
Join Clinical Trials for Asperger's Syndrome (ASD) |
